Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
FDA+ channel feed
Sun Pharma temporarily halts shipments from manufacturing plant after FDA letter
3 years ago
Manufacturing
FDA approves Biogen’s ALS drug tofersen, paving new road for accelerated pathway in neuro diseases
3 years ago
Pharma
FDA hands Arbutus clinical hold on IND for hepatitis PD-L1
3 years ago
On Vertex and CRISPR Therapeutics’ heels, bluebird submits sickle cell gene therapy to FDA
3 years ago
R&D
Cell/Gene Tx
FDA puts second Foghorn study on partial hold after serious heart event
3 years ago
FDA lifts nearly two-year hold on MaaT Pharma's microbiome therapy, opens door to PhIII
3 years ago
FDA pushes back PDUFA date for Daiichi's AML drug quizartinib over REMS updates
3 years ago
Outgoing regulatory chief details hiring and retention challenges for FDA inspectors
3 years ago
Manufacturing
FDA greenlights Roche's Polivy, expanding label into first-line DLBCL combo therapy
3 years ago
Pharma
FDA's pain adcomm debates clinical trial designs for opioid post-marketing trials
3 years ago
R&D
Pharma
Ireland added to EMA/FDA joint generic inspection initiative
3 years ago
Manufacturing
Four senior FDA leaders forged close ties with Biogen well ahead of Aduhelm's approval. Now they've left FDA
3 years ago
People
FDA simplifies Covid-19 bivalent vaccination process ahead of June adcomm
3 years ago
Pharma
Coronavirus
Avenue touts progress with FDA on embattled pain candidate after two CRLs, failed adcomm
3 years ago
Adcomm unanimously recommends Entasis' bacterial pneumonia candidate for resistant infections
3 years ago
Gamida Cell wins FDA approval for new cord blood-based therapy for cancer patients
3 years ago
Abortion pill can't just 'snap back' to pre-2016, FDA's Woodcock tells SCOTUS
3 years ago
FDA adcomm votes in favor of first drug for agitation associated with Alzheimer's dementia
3 years ago
Troubled Reykjavik plant lands Alvotech a second CRL for its potential Humira biosimilar
3 years ago
FDA rejects Lilly's ulcerative colitis drug mirikizumab over manufacturing issues
3 years ago
Pharma
Appeals court temporarily keeps abortion pill on the market, but FDA may have to revert to older restrictions
3 years ago
Law
Ghana approves Oxford University's malaria vaccine for children
3 years ago
FDA may need to 'get creative' if abortion pill approval pulled this week
3 years ago
Biotech execs say mifepristone decision would 'upend' FDA's new drug application process
3 years ago
Pharma
First page
Previous page
56
57
58
59
60
61
62
Next page
Last page